NCT06509906 2025-12-18
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
EMD Serono
Phase 1 Terminated
EMD Serono
Lumos Pharma
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)